Singapore markets closed

Ikena Oncology, Inc. (IKNA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.2900-0.0600 (-4.44%)
At close: 04:00PM EDT
1.3400 +0.05 (+3.88%)
After hours: 04:22PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
30,385
9,160
15,618
30,985
9,194
Operating expenses
Research development
61,020
59,652
64,321
47,108
44,847
Selling general and administrative
22,363
24,925
22,201
18,015
8,866
Total operating expenses
83,383
84,577
86,522
65,123
53,713
Operating income or loss
-52,998
-75,417
-70,904
-34,138
-44,519
Total other income/expenses net
7,089
7,089
2,139
23
263
Income before tax
-51,871
-68,328
-68,765
-34,115
-44,256
Income tax expense
-162
-162
0
-
-
Income from continuing operations
-51,871
-68,166
-68,765
-34,115
-44,256
Net income
-51,871
-68,166
-68,765
-34,115
-44,256
Net income available to common shareholders
-51,871
-68,166
-68,765
-34,115
-44,256
Basic EPS
-1.62
-
-1.90
-1.22
-1.28
Diluted EPS
-1.62
-
-1.90
-1.22
-1.28
Basic average shares
38,831
-
36,188
27,983
34,588
Diluted average shares
38,831
-
36,188
27,983
34,588